DIRECT HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC SEPARATION OF THE RACEMATES AND DIASTEREOMERS OF NADOLOL

被引:7
作者
HOSHINO, M
MATSUI, E
YAJIMA, K
OKAHIRA, A
机构
[1] Central Research Laboratories, Zeria Pharmaceutical Co., Ltd., Osato-gun, Saitama, 360-01, 2512-1, Oshikiri, Konan-machi
关键词
D O I
10.1016/0021-9673(94)80634-9
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The direct separation of the two racemates and four diastereomers of nadolol by high-performance liquid chromatography (HPLC) is described. The racemates were well separated on non-chiral ODS columns using mixtures of phosphate buffer and methanol. The diastereomers could be separated on commercial chiral columns, using organic and aqueous mobile phases. The analytical HPLC method using an organic mobile phase was applied to semi-preparative HPLC for diastereomers.
引用
收藏
页码:104 / 110
页数:7
相关论文
共 8 条
[1]   DIRECT SEPARATION OF NADOLOL ENANTIOMERS ON A PIRKLE-TYPE CHIRAL STATIONARY PHASE [J].
DYAS, AM ;
ROBINSON, ML ;
FELL, AF .
JOURNAL OF CHROMATOGRAPHY, 1991, 586 (02) :351-355
[2]  
FUJIMA H, 1992, CHROMATOGRAPHY, V13, P385
[3]  
HAGINAKA J, 1992, J CHROMATOGR, V598, P351
[4]   NADOLOL - HIGH-PRESSURE LIQUID-CHROMATOGRAPHIC METHODS FOR ASSAY, RACEMATE COMPOSITION AND RELATED-COMPOUNDS [J].
LACROIX, PM ;
CURRAN, NM ;
LOVERING, EG .
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1992, 10 (10-12) :917-924
[5]   LIQUID AND HIGH-PRESSURE CARBON-DIOXIDE CHROMATOGRAPHY OF BETA-BLOCKERS - RESOLUTION OF THE ENANTIOMERS OF NADOLOL [J].
LEE, CR ;
PORZIEMSKY, JP ;
AUBERT, MC ;
KRSTULOVIC, AM .
JOURNAL OF CHROMATOGRAPHY, 1991, 539 (01) :55-69
[6]   SEPARATION OF NADOLOL DIASTEREOISOMERS BY REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
MATSUTERA, E ;
NOBUHARA, Y ;
NAKANISHI, Y .
JOURNAL OF CHROMATOGRAPHY, 1981, 216 (OCT) :374-379
[7]   CHIRAL SEPARATION OF CATIONIC DRUGS ON AN ALPHA-1-ACID GLYCOPROTEIN BONDED STATIONARY PHASE [J].
SCHILL, G ;
WAINER, IW ;
BARKAN, SA .
JOURNAL OF LIQUID CHROMATOGRAPHY, 1986, 9 (2-3) :641-666
[8]  
SLUSAREK L, 1980, ANAL PROFILES DRUG S, V9, P455